UY34504A - Prevention of adverse effects caused by bispecific antibodies EpCAMxCD3 - Google Patents
Prevention of adverse effects caused by bispecific antibodies EpCAMxCD3Info
- Publication number
- UY34504A UY34504A UY0001034504A UY34504A UY34504A UY 34504 A UY34504 A UY 34504A UY 0001034504 A UY0001034504 A UY 0001034504A UY 34504 A UY34504 A UY 34504A UY 34504 A UY34504 A UY 34504A
- Authority
- UY
- Uruguay
- Prior art keywords
- epcamxcd3
- prevention
- adverse effects
- bispecific antibodies
- effects caused
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
No escanear figura.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161569180P | 2011-12-09 | 2011-12-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY34504A true UY34504A (en) | 2013-06-28 |
Family
ID=47520027
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY0001034504A UY34504A (en) | 2011-12-09 | 2012-12-07 | Prevention of adverse effects caused by bispecific antibodies EpCAMxCD3 |
Country Status (5)
| Country | Link |
|---|---|
| AR (1) | AR089114A1 (en) |
| AU (1) | AU2012350429A1 (en) |
| TW (1) | TW201322985A (en) |
| UY (1) | UY34504A (en) |
| WO (1) | WO2013083809A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL1874821T3 (en) | 2005-04-26 | 2013-09-30 | Trion Pharma Gmbh | Combination of antibodies and glucocorticoids for treating cancer |
| BR112017024757A2 (en) | 2015-05-18 | 2018-11-13 | TCR2 Therapeutics Inc. | compositions and methods for reprogramming tcr using fusion proteins |
| US12128102B2 (en) | 2016-03-08 | 2024-10-29 | Takeda Pharmaceutical Company Limited | Constrained conditionally activated binding proteins |
| IL302613B1 (en) | 2017-09-08 | 2024-12-01 | Maverick Therapeutics Inc | Binding proteins are activated under limited conditions |
| US11685780B2 (en) | 2019-03-05 | 2023-06-27 | Takeda Pharmaceutical Company Limited | Single domain antigen binding domains that bind human Trop2 |
| WO2023044039A1 (en) * | 2021-09-16 | 2023-03-23 | TCR2 Therapeutics Inc. | Compositions and methods for treating cancer |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| DE3883899T3 (en) | 1987-03-18 | 1999-04-22 | Sb2, Inc., Danville, Calif. | CHANGED ANTIBODIES. |
| AU612370B2 (en) | 1987-05-21 | 1991-07-11 | Micromet Ag | Targeted multifunctional proteins |
| WO2004106383A1 (en) | 2003-05-31 | 2004-12-09 | Micromet Ag | Pharmaceutical composition comprising a bispecific antibody for epcam |
| US8076459B2 (en) | 2003-10-16 | 2011-12-13 | Micromet Ag | Multispecfic deimmunized CD3-binders |
| PL1874821T3 (en) * | 2005-04-26 | 2013-09-30 | Trion Pharma Gmbh | Combination of antibodies and glucocorticoids for treating cancer |
| MX2009010611A (en) | 2007-04-03 | 2010-03-26 | Micromet Ag | Cross-species-specific bispecific binders. |
| FI2155783T4 (en) | 2007-04-03 | 2022-12-15 | Cross-species-specific cd3-epsilon binding domain | |
| RU2547600C2 (en) | 2008-10-01 | 2015-04-10 | Эмджен Рисерч (Мьюник) Гмбх | Pscaxcd3, cd19xcd3, c-metxcd3, endosialin xcd3, epcamxcd3, igf-1rxcd3 or fap-alpha xcd3 bispecific single-chain antibody with inter-species specificity |
| MX2012003175A (en) | 2009-09-18 | 2012-04-11 | Micromet Ag | Dosage regimen for administering an epcamxcd3 bispecific antibody. |
-
2012
- 2012-12-07 UY UY0001034504A patent/UY34504A/en not_active Application Discontinuation
- 2012-12-07 WO PCT/EP2012/074855 patent/WO2013083809A1/en active Application Filing
- 2012-12-07 AR ARP120104599A patent/AR089114A1/en not_active Application Discontinuation
- 2012-12-07 AU AU2012350429A patent/AU2012350429A1/en not_active Abandoned
- 2012-12-10 TW TW101146446A patent/TW201322985A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2012350429A1 (en) | 2013-07-11 |
| AR089114A1 (en) | 2014-07-30 |
| TW201322985A (en) | 2013-06-16 |
| WO2013083809A1 (en) | 2013-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY34206A (en) | INTERLEUCINE MONOCLONAL ANTIBODY-31 | |
| UY33925A (en) | TRICYCLIC QUINASE INHIBITORS | |
| CR20130278A (en) | PREVENTION OF ADVERSE EFFECTS CAUSED BY SPECIFIC UNION DOMAIN CD3 | |
| UY34156A (en) | METALOENZYM INHIBITING COMPOUNDS | |
| UY34410A (en) | BISPECIFIC IMMUNOLIGANTS DIRECTED AGAINST TNF | |
| CR20140024A (en) | METALOENZYM INHIBITING COMPOUNDS | |
| UY34145A (en) | METALOENZYM INHIBITING COMPOUNDS | |
| UY34456A (en) | ANTI-IL-36R ANTIBODIES | |
| UA109931C2 (en) | PIRIMIDINCYCLOHEXYL MODULATORS OF GLUCOCORTICOID RECEPTORS | |
| EA201692412A1 (en) | SYNTHESIS OF POLYCYCLIC CARBAMOILPYRIDONE COMPOUNDS | |
| UY34472A (en) | MODIFIED DERIVATIVES OF 4-PHENYL-PYRIDINE | |
| UY33958A (en) | GLUCOSILCERAMIDE SINTASA INHIBITORS | |
| EP3418306C0 (en) | IMPROVED ASSEMBLY OF BISPECIFIC ANTIBODIES | |
| UY34074A (en) | HIGHLY CONCENTRATED OLOPATADINE OPHTHALMIC COMPOSITION | |
| UY33977A (en) | HYBRID OF SELF-BINDING PIGMENT. | |
| UY33931A (en) | BISPECIFIC UNION AGENTS | |
| UY34654A (en) | BETA-SECRETASA INHIBITORS | |
| CR20130539A (en) | TRIAZOLOPIRIDINS | |
| EA201391389A1 (en) | CRYSTALS OF ANTIBODIES AGAINST SKLEROSTIN AND COMPOSITIONS ON THEIR BASIS | |
| UY33930A (en) | NEW QUINASE INHIBITORS | |
| UY33957A (en) | MODULATORS OF NUCLEAR HORMONE RECEPTORS | |
| UY34006A (en) | IMIDAZOPIRIDAZINAS | |
| UY34141A (en) | CLEANING COMPOSITIONS OF LIQUID SALT | |
| UY4153Q (en) | DRUMS | |
| UY34483A (en) | POLYPEPTIDE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20201020 |